Rebecca Weimer
University of Maryland, Baltimore(US)Mirna Therapeutics (United States)(US)
Publications by Year
Research Areas
biodegradable polymer synthesis and properties, Synthesis and properties of polymers, Parkinson's Disease Mechanisms and Treatments, Advanced Polymer Synthesis and Characterization, Advancements in Transdermal Drug Delivery
Most-Cited Works
- → Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery(2011)420 cited
- → Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications(2016)172 cited
- → Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit(2013)68 cited
- → Tuning drug release from polyoxazoline-drug conjugates(2019)50 cited
- → Poly(oxazolines)(2018)19 cited
- → Overcoming the PEG dilemma with Poly(2-ethyl-2-oxazoline) lipids in lipid nanoparticle formulations(2025)3 cited
- → The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocol(2024)2 cited
- → Corrigendum to “Overcoming the PEG dilemma with Poly(2-ethyl-2-oxazoline) lipids in lipid nanoparticle formulations”. [Eur. Polym. J. 241 (2025) 114392](2025)
- → List of contributors(2018)
- → Recruitment strategies for the racial disparities in Parkinson's disease study: Partnering with patients from the Black community(2025)